Hyloris Pharmaceuticals SA

EBR:HYL.BR

5.8 (EUR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -4.373-4.373-3.317-3.317-3.482-3.482-4.942-2.471-3.339-1.67-8.24-4.12-1.702-1.702-2.478-1.264-2.148-2.148-0.753-0.561
Depreciation & Amortization 0.0680.0680.0820.0820.0270.0270.0550.0280.0880.0440.0260.0130.0250.0250.0280.0240.0260.0260.0220.029
Deferred Income Tax -1.21101.1870-2.6830-0.71800000000-0.1130000
Stock Based Compensation 0.1140.1140.1570.1570.1430.1430.1370.1370.1580.1580.1310.1310.1210.1210.130.1130000
Change In Working Capital -0.291-0.2910.8830.883-0.303-0.303-1.679-0.4551.0510.214-1.828-0.6020.0250.0253.42-1.317-1.544-1.5440.277-0.143
Accounts Receivables -0.403-0.4030.4170.417-0.61-0.610.2980.149-0.238-0.119-1.83-0.9150.0880.0881.315-1.4090.1250.125-0.3870.945
Change In Inventory 00000000000000000000
Change In Accounts Payables 0.20100.84900.3010-0.76901.7630-0.625000000000
Other Working Capital 0.1120.1120.4660.4660.3070.307-1.208-0.604-0.4740.3330.6270.314-0.063-0.0630.1051.369-1.669-1.6690.799-0.247
Other Non Cash Items 0.1430.1430.1320.1320.3050.305-0.519-0.439-1.1170.2713.267-0.063-0.802-0.8021.4390.1131.841.840.218-0.823
Operating Cash Flow -4.34-4.34-2.064-2.064-3.31-3.31-7.666-3.201-1.968-0.984-9.282-4.641-2.333-2.3332.539-2.444-1.826-1.826-0.236-0.675
Investing Activities:
Investments In Property Plant And Equipment -0.149-0.149-0.2360-0.036-0.036-0.212-0.015-0.907-0.052-0.154-0.00200-0.247-0.24-0.004-0.004-0.568-0.035
Acquisitions Net 00000000000000000000
Purchases Of Investments 00000.0220-0.5220-1.1660-1.283000000000
Sales Maturities Of Investments 10.00100000000000000000-0.0030.003
Other Investing Activites 5.1385.138-0.044-0.044-5.284-5.284-0.352-0.352-0.877-0.8770.219-0.607-0.073-0.073-0.247-0.24-0.309-0.309-0.571-0.032
Investing Cash Flow 4.9894.989-0.044-0.044-5.32-5.32-0.734-0.367-1.857-0.929-1.218-0.609-0.073-0.073-0.247-0.24-0.313-0.313-0.571-0.032
Financing Activities:
Debt Repayment -0.0070-0.0440-6.3170-1.0590-0.3470-0.409000-8.065-0.01100-0.013-0.013
Common Stock Issued 000017.17000000000000000
Common Stock Repurchased 00000000000000000000
Dividends Paid 00000000000000000000
Other Financing Activities -0.026-0.026-0.04-0.04-3.486-3.48617.1697.4050.1860.186-0.217-0.2171.2141.21461.34413.7021.6671.667-0.5460.546
Financing Cash Flow -0.026-0.026-0.04-0.04-3.486-3.48616.0757.4050.3720.186-0.434-0.2171.2141.21453.27913.6911.6671.667-0.5590.533
Other Information:
Effect Of Forex Changes On Cash -100-0.00100000000000-0.0010.001000.001-0.001
Net Change In Cash -8.7530.624-4.298-2.148-14.23-12.1157.6753.838-3.453-1.727-10.934-5.467-1.192-1.19255.5711.008-0.471-0.471-1.365-0.175
Cash At End Of Period 30.4060.51939.159-2.14843.457-12.11557.6873.83850.01251.73953.465-5.467-1.19265.59166.78311.213-0.4710.6761.1472.512